ANGELA HANCOCK: Open Payments
NPI 1447336292 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 24 payments from 8 companies in 2025. Trend: 2023 $19 · 2024 $328 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 7 | $164 |
| Novo Nordisk Inc | 4 | $97 |
| Amgen Inc. | 4 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $51 |
| CVRx, Inc. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| Esperion Therapeutics, Inc. | 2 | $34 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $26 |
Products named: LEQVIO, Wegovy, REPATHA, Barostim Neo System, WAINUA, NEXLETOL, LifeVest, ENTRESTO.
Industry payments across FL — which companies pay providers there.
